Molecular targeting in radiotherapy of lung cancer
- 1 August 2004
- journal article
- conference paper
- Published by Elsevier in Lung Cancer
- Vol. 45, S187-S197
- https://doi.org/10.1016/j.lungcan.2004.07.975
Abstract
No abstract availableKeywords
This publication has 77 references indexed in Scilit:
- Bowman–Birk protease inhibitor activates DNA‐dependent protein kinase and reduces formation of radiation‐induced dicentric chromosomesInternational Journal of Radiation Biology, 2003
- Enhancement of tumor radioresponse by combined treatment with gefitinib (Iressa, ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor, is accompanied by inhibition of DNA damage repair and cell growth in oral cancerInternational Journal of Cancer, 2003
- Combined-Modality Treatment of Solid Tumors Using Radiotherapy and Molecular Targeted AgentsJournal of Clinical Oncology, 2003
- Novel Targets for Lung Cancer Therapy: Part IIJournal of Clinical Oncology, 2002
- Entwicklungen in der primären Strahlentherapie und Radiochemotherapie beim nichtklein-zelligen BronchialkarzinomDer Onkologe, 2002
- Irradiated homozygous TGF- β 1 knockout fibroblasts show enhanced clonogenic survival as compared with TGF- β 1 wild-type fibroblastsInternational Journal of Radiation Biology, 2002
- O-phospho-L-tyrosine protects TP53 wild-type cells against ionizing radiationInternational Journal of Cancer, 2001
- The Hallmarks of CancerCell, 2000
- Enhancement of Sensitivity of Human Squamous Carcinoma Cells to Radiation by Epidermal Growth FactorJNCI Journal of the National Cancer Institute, 1989
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971